4

PRIMARY DOCUMENT

Company: PALVELLA THERAPEUTICS, INC.
Filed: May 30, 2023
Period of Report: May 25, 2023
Accession Number: 0001562180-23-004575

View Document ↗ View on SEC.gov ↗